Block listing Interim Review

RNS Number : 0764Z
Advanced Medical Solutions Grp PLC
15 September 2020


15 September 2020

  Advanced Medical Solutions Group plc

(“AMS”, the “Company” or the “Group”)

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:

 

Name of applicant:

Advanced Medical Solutions Group plc

Name of scheme:

Block Scheme for:

1.   Deferred Share Bonus Scheme

2.   Enterprise Management Incentive Scheme

3.   Company Share Option Plan

4.   Unapproved Executive Share Option Scheme

5.   Long Term Incentive Plan

6.   Deferred Annual Bonus Scheme

Period of return:

From:

6 March 2020

To:

5 September 2020

Balance of unallotted securities under scheme(s) from previous return:

1. 627,091

2. 15,000

3. 323,733

4. 954,197

5. 776,034

6. 407,111

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil

Less:  Number of securities issued/allotted under scheme(s) during period:

1. 102,943

2. 15,000

3. 6,220

4. 25,293

5. 5,616

6. 39,618

 

 

 

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1. 524,148

2. Nil

3. 317,513

4. 928,904

5. 770,418

6. 367,493

Number and class of securities originally listed and the date of admission:

4,476,264 ordinary shares of 5p each on 6 September 2018

 

 

Name of contact:

Eddie Johnson

Telephone number of contact:

01606 545506

 

 

For further information, please visit www.admedsol.com or contact:

 

 

Advanced Medical Solutions Group plc

Tel: 44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer




Consilium Strategic Communications

Tel: 44 (0) 20 3709 5700

Mary-Jane Elliott / Matthew Neal / Olivia Manser




Investec Bank PLC – Nominated Adviser & Broker

Tel: 44 (0) 20 7597 5970

Daniel Adams / Patrick Robb / Gary Clarence


 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLRGPUQCBUPUGWA